Interchangeability of the EQ-5D and the SF-6D, and comparison of their psychometric properties in a spinal postoperative Spanish population

[1] Brazier J(1990)EuroQol—a new facility for the measurement of health-related quality of life Health Policy 16 199-208

[2] Roberts J(2002)The estimation of a preference-based measure of health from the SF-36 J. Health Econ. 21 271-292

[3] Deverill M(1992)The MOS 36-Item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection Med Care 30 473-483

[4] Ware JE(1996)A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity Med. Care 34 220-233

[5] Sherbourne CD(2009)Comparing cost-utility estimates Med. Care 47 889-894

[6] Ware J(2009)SF-6D versus EQ-5D: reasons for differences in utility scores and impact on reported cost-utility Eur. J. Health Econ. 10 15-23

[7] Kosinski M(2010)The impact of differences in EQ-5D and SF-6D utility scores on the acceptability of cost-utility ratios: results across five trial-based cost-utility studies Value Health 13 222-229

[8] Keller SD(2007)Measuring Preferences for cost-utility analysis Pharmacoeconomics 25 93-106

[9] Sach TH(2009)Comparing SF-6D and EQ-5D utilities across groups differing in health status Qual. Life Res. 18 87-97

[10] Barton GR(2005)An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population Health Econ. 14 1169-1189

[1] Brazier J(1990)EuroQol—a new facility for the measurement of health-related quality of life Health Policy 16 199-208

[2] Roberts J(2002)The estimation of a preference-based measure of health from the SF-36 J. Health Econ. 21 271-292

[3] Deverill M(1992)The MOS 36-Item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection Med Care 30 473-483

[4] Ware JE(1996)A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity Med. Care 34 220-233

[5] Sherbourne CD(2009)Comparing cost-utility estimates Med. Care 47 889-894

[6] Ware J(2009)SF-6D versus EQ-5D: reasons for differences in utility scores and impact on reported cost-utility Eur. J. Health Econ. 10 15-23

[7] Kosinski M(2010)The impact of differences in EQ-5D and SF-6D utility scores on the acceptability of cost-utility ratios: results across five trial-based cost-utility studies Value Health 13 222-229

[8] Keller SD(2007)Measuring Preferences for cost-utility analysis Pharmacoeconomics 25 93-106

[9] Sach TH(2009)Comparing SF-6D and EQ-5D utilities across groups differing in health status Qual. Life Res. 18 87-97

[10] Barton GR(2005)An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population Health Econ. 14 1169-1189